M, H., J, A., M, C., J, G., S, B., C, M., . . . R, W. (2024). Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i. Cardiovascular diabetology, 23(1), 199. https://doi.org/10.1186/s12933-024-02288-x
Chicago Style (17th ed.) CitationM, Harada, et al. "Bidirectional Modulation of TCA Cycle Metabolites and Anaplerosis by Metformin and Its Combination with SGLT2i." Cardiovascular Diabetology 23, no. 1 (2024): 199. https://doi.org/10.1186/s12933-024-02288-x.
MLA (9th ed.) CitationM, Harada, et al. "Bidirectional Modulation of TCA Cycle Metabolites and Anaplerosis by Metformin and Its Combination with SGLT2i." Cardiovascular Diabetology, vol. 23, no. 1, 2024, p. 199, https://doi.org/10.1186/s12933-024-02288-x.